Literature DB >> 2998183

Concomitant inheritance of alpha-thalassemia in beta 0- thalassemia/Hb E disease.

P Winichagoon, S Fucharoen, D Weatherall, P Wasi.   

Abstract

Concomitant inheritance of alpha-thalassemia in patients with beta 0-thalassemia/hemoglobin (Hb) E disease was detected by restriction endonuclease DNA mapping. Among 42 patients with beta 0-thalassemia/Hb E disease, seven were found to have an alpha-thalassemia-2 haplotype. Of these, five belonged to the rightward or 3.7-kb type of alpha-thalassemia-2 and the remaining two the leftward or 4.2-kb type. All the seven patients with alpha-thalassemia-2 haplotype had hemoglobin levels of 7.4 g/dl or above; those without detectable alpha-thalassemia had hemoglobin levels both higher and lower than 7.4 g/dl. The latter attended the clinic regularly, the former did occasionally. These findings suggest that concomitant inheritance of alpha-thalassemia can alleviate the severity of beta 0-thalassemia/Hb E disease. Failure to find alpha-thalassemia-1 haplotype in these patients suggests that concomitant inheritance of alpha-thalassemia-1 with beta 0-thalassemia/Hb E might lead to so mild a condition that the individuals do not present clinically. The fact that many patients without a detectable alpha-thalassemia haplotype also had hemoglobin levels of 7.4 g/dl or higher suggests that there are additional factors responsible for the mildness of beta 0-thalassemia/Hb E disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998183     DOI: 10.1002/ajh.2830200303

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Descriptive profile of β-thalassemia mutations in West Bengal population: a hospital-based study.

Authors:  Deboshree M Bhattacharyya; Ashis Mukhopadhyay; Jayasri Basak
Journal:  Int J Hematol       Date:  2014-02-01       Impact factor: 2.490

2.  Structural and functional studies indicating altered redox properties of hemoglobin E: implications for production of bioactive nitric oxide.

Authors:  Camille J Roche; Vladimir Malashkevich; Tatiana C Balazs; David Dantsker; Qiuying Chen; Juan Moreira; Steven C Almo; Joel M Friedman; Rhoda Elison Hirsch
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

Review 3.  Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.

Authors:  Paul J Schmidt; Mark D Fleming
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-18       Impact factor: 3.722

Review 4.  The hemoglobin E thalassemias.

Authors:  Suthat Fucharoen; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

5.  Hemoglobin E: a common hemoglobinopathy among children of Southeast Asian origin.

Authors:  E Katsanis; K H Luke; E Hsu; J R Yates
Journal:  CMAJ       Date:  1987-07-01       Impact factor: 8.262

Review 6.  Haemoglobinopathies in southeast Asia.

Authors:  Suthat Fucharoen; Pranee Winichagoon
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

Review 7.  Hb E/beta-thalassaemia: a common & clinically diverse disorder.

Authors:  Nancy F Olivieri; Zahra Pakbaz; Elliott Vichinsky
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

8.  Forager and farmer evolutionary adaptations to malaria evidenced by 7000 years of thalassemia in Southeast Asia.

Authors:  Melandri Vlok; Hallie R Buckley; Justyna J Miszkiewicz; Meg M Walker; Kate Domett; Anna Willis; Hiep H Trinh; Tran T Minh; Mai Huong T Nguyen; Lan Cuong Nguyen; Hirofumi Matsumura; Tianyi Wang; Huu T Nghia; Marc F Oxenham
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

9.  Shared molecular basis, diagnosis, and co-inheritance of alpha and beta thalassemia.

Authors:  Govinda Khatri; Abdul Moiz Sahito; Saboor Ahmed Ansari
Journal:  Blood Res       Date:  2021-12-31

10.  Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.

Authors:  Olivier Negre; Anne-Virginie Eggimann; Yves Beuzard; Jean-Antoine Ribeil; Philippe Bourget; Suparerk Borwornpinyo; Suradej Hongeng; Salima Hacein-Bey; Marina Cavazzana; Philippe Leboulch; Emmanuel Payen
Journal:  Hum Gene Ther       Date:  2016-02       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.